NEW YORK, June 27, 2023 — NASHNET, a Kinetix Group network of excellence dedicated to advancing care pathways for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), announced the release of an innovative white paper. The paper is titled Biomarkers for Diagnosing and Staging Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Current Perspectives and Potential Future Applications.
Tag: biomarkers
NASHNET Biomarkers White Paper
In support of the Global Liver Institute campaign for International NASH Day, NASHNET developed a groundbreaking white paper titled “Biomarkers for Diagnosing and Staging Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): Current Perspectives and Potential Future Applications.” The white paper sheds light on guideline-directed and optimal use of biomarkers to diagnose or stage NASH. Special thanks… Continue reading NASHNET Biomarkers White Paper